Preclinical prevent cancer program: preclinical efficacy and intermediate endpoint biomarkersperiod of performance: 9/22/2015 - 9/21/2018

Ended Awarded Sep 22, 2015 Last action Sep 14, 2022

Contract number: HHSN261201500042I
Awardee: IIT Research Institute UEI DGBUFQYMKWB5 Part of Illinois Institute Of Technology
Awarding agency: National Cancer Institute National Institutes of Health, Department of Health and Human Services
Task orders: 3 $1,571,014 obligated

Award facts

Opportunity: NO1CN500347 Solicitation number
Combined order value: $1,571,014 Current and potential, with all options
Last date to order 100% complete: Sep 21, 2018
IDV ceiling 5% used: $29,800,000.00
Award type: Multiple award
Who can order: Only the awarding agency
NAICS code: 541711 Research and Development in Biotechnology
PSC: AN11 Health R&D Services; Health Care Services; Basic Research
Set-aside: No set-aside
Competition: Full and Open Competition · 9 offers Negotiated Proposal / Quote
Pricing: Order Dependent (IDV only)

Award details come from SAM.gov/FPDS.

Task order	Ordering agency	Obligated	Awarded
Preclinical efficacy evaluation of the lipid-based smedds formulation of DIM, BR-9001, to award 3 75N91018F00003	National Cancer Institute (NIH)	$970,988	Aug 8, 2018
Novel androgen receptor antagonist-mediated chemoprevention of prostate cancer HHSN26100002	National Cancer Institute (NIH)	$596,209	Sep 24, 2015
Contract orientation kickoff meeting PP: 9/22/2015 to 12/31/2015 HHSN26100001	National Cancer Institute (NIH)	$3,817	Sep 22, 2015

Action	Obligated	Date
Other Administrative Action P00004	$0	Sep 14, 2022
Other Administrative Action P00003	$0	Jun 8, 2022
Additional Work (new agreement, FAR part 6 applies) 2 · Preclinical prevent efficacy- IDIQ programmatic maximum increase	$0	Jun 19, 2018
Other Administrative Action 1	$0	May 12, 2016
Original award	$0	Sep 22, 2015

HHSN261201500042I was awarded to IIT Research Institute by National Cancer Institute (National Institutes of Health) on September 22, 2015.

Orders under HHSN261201500042I have obligated $1,571,014. HHSN261201500042I's own ceiling is $29,800,000.

3 orders have been placed under HHSN261201500042I, the latest on August 8, 2018.

HHSN261201500042I is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.

Yes. HHSN261201500042I is part of PREVENT Cancer Program (PREVENT).

The extent of competition for HHSN261201500042I was full and open competition. The government received 9 offers.

On GovTribe

Try for free Login